Lung Cancer Trial, Recruiting NCT05898594 Sponsor: Massachusetts General Hospital Condition: Lung Cancer
Back to Lung Cancer

Lung Cancer Trial, Recruiting

NCT05898594
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You identify yourself as Black.
  • You have smoked at some point in your life (there is no minimum amount you must have smoked, and former smokers can apply no matter how long ago they quit).
  • You are between 50 and 80 years old.

Who may not be able to join:

  • You have previously been diagnosed with lung cancer.
  • You are currently experiencing any of the following symptoms: shortness of breath, getting winded easily, or a ongoing cough lasting more than 12 weeks that has not gotten better (if you have any of these symptoms, the trial advises you to contact your regular doctor).
  • You had pneumonia or a serious respiratory infection within the last 12 weeks that required antibiotic treatment.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 15 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Chi Fu Jeffrey Yang, MD, Massachusetts General Hospital

Phone: 617-724-1681

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
6 September 2023
Est. completion
30 June 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Proportion of Enrolled Participants; Proportion of Participants with Positive Low-dose Computed Tomography Test; Proportion of Participants Diagnosed with Invasive Lung Cancer; Distribution of Lung Imaging Reporting and Data System (Lung-RADS) Scores

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov